FDA Delivers Regenxbio Another Blow, This Time for RGX-121

 
• By Alaric DeArment
  
Setback
Regexbio got a CRL from the FDA for RGX-121 in MPS II. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies